UNSPSC 51402203: Buspirone

This classification denotes an anxiolytic with the molecular formula C21H31N5O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TK65WKS8HL, chemically known as 8-azaspiro(4,5)decane-7,9-dione, 8-(4-(4-(2-pyrimidinyl)piperizinyl)butyl)- but generally known as buspirone, which bears US NIH Compound Identifier 2477. Buspirone most often comes in base and hydrochloride forms. European Medicines Agency schedules Buspirone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05992MIG.

UNSPSC 51402203 Buspirone is a Commodity code that captures pharmaceutical products, though the recent state and local procurement activity under this code does not align with buspirone specifically. Seminole County, Florida's most recent solicitation tagged to this code—IFB60459723LAS, posted June 30, 2026—actually procures naloxone and safe drug deactivation systems for community health and opioid-response initiatives, not psychiatric medications. The mismatch suggests either a data-entry error in the code assignment or a taxonomy misalignment in how the county's procurement system categorizes pharmaceutical purchases. State and local governments use pharmaceutical commodity codes to purchase medications for public health programs, emergency medical services, correctional health systems, and community health departments, but the actual goods being bought under this code number do not match the nominal pharmaceutical category name.

Seminole County represents the only recent activity visible under this code. The county's IFB seeks 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, with responses due July 26, 2023 (noting the due date appears inconsistent with the June 2026 posting date in the source). The contract carries a two-year initial term with a one-year renewal option, E-Verify compliance and drug-free workplace certification requirements, and potential FEMA funding with attendant federal compliance obligations. Given the single recent opportunity and the code-scope mismatch, this code shows minimal current activity for buspirone or related psychiatric pharmaceuticals in state and local procurement.